Precision proton beams target tough esophageal tumors before surgery
NCT ID NCT02213497
Summary
This early-phase study aims to find the safest, most effective dose of proton beam radiation when given with chemotherapy before surgery for locally advanced esophageal cancer. It will enroll about 30 patients who are candidates for surgery to test this combined approach. The main goal is to see how well patients tolerate the treatment and to measure how much the tumor shrinks before it is surgically removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.